Nature, Published online: 04 February 2026; doi:10.1038/s41586-025-10005-1

The ZFTA–RELA fusion, an oncogene for ependymomas, promotes the production of itaconate, and its dependence on this metabolite represents a new therapeutic target for this cancer.


From Nature via this RSS feed